Foundations

The biology behind everything else. The hallmarks of aging give a framework for what every intervention is targeting; the Blue Zones offer a behavioral pattern (with caveats); the bile-microbiome axis links nutrition, metabolism, and the brain. Two more — heart-rate variability as a continuous read on autonomic aging, and purpose-in-life as one of the most underrated psychosocial mortality levers — round out the picture.

What's actually going on biologically when we age, and what frameworks should we use to make sense of it?

The contemporary geroscience model holds that biological aging itself is the primary risk factor for most non-communicable diseases — cardiovascular, neurodegenerative, oncologic, metabolic. Targeting the underlying mechanisms of aging may delay multiple morbidities simultaneously.

Five frameworks worth understanding

1. The Hallmarks of Aging

The dominant biological framework — twelve interconnected hallmarks (originally nine in 2013, expanded in 2023 Cell) that drive senescence. Provides the theoretical basis for nearly every "anti-aging" intervention.

Hallmarks of aging

2. The Blue Zones

Five regions with documented exceptional longevity — Sardinia, Okinawa, Nicoya, Ikaria, Loma Linda. The data has limitations (some demographic claims have been challenged), but the behavioral commonalities are remarkably consistent and replicate across rigorous cohort studies elsewhere.

Blue Zones

3. The Bile-Microbiome-Metabolism Axis

A more recent integrative framework. Bile acids are signaling molecules — not just digestive aids — and their interaction with the gut microbiome regulates inflammation, glucose metabolism, lipid handling, and the gut-liver-brain axis.

Bile and metabolism

4. Heart Rate Variability — the autonomic biomarker

The millisecond fluctuations between heartbeats turn out to be one of the most informative continuously-measurable signals about how well a body is coping. HRV tracks vagal tone, biological aging, systemic inflammation, mood, and training readiness — and modern wearables can capture it every night, with some caveats about which devices actually do it well.

Heart rate variability

5. Purpose in Life

A measurable psychological construct with effect sizes on dementia, mortality, and adiposity that hold up against most physical-health interventions. The Wisconsin Longitudinal Study (28-year follow-up) identified late midlife (~63–70) as the critical window where purpose maintenance most strongly protects later cognition. Tightly intertwined with social connection — most lasting purpose routes through people.

Purpose

The healthspan vs. lifespan distinction

  • Lifespan: chronological duration of life
  • Healthspan: period of life spent free from chronic disease, cognitive decline, and disability

The goal of geroscience is to compress morbidity — narrow the gap between healthspan and lifespan, so the period of disability and dependence at the end of life is short.

This reframes most longevity interventions: their value is in pushing back the onset of morbidity, not necessarily in extending the absolute end-of-life date.

Inherited vs. modifiable

Inherited genetic sequence variants account for an estimated 15–25% of lifespan variance. The remaining 75–85% is dictated by environmental factors continuously codified in the epigenome.

This is why behavior dominates: even if you're dealt an unfavorable genetic hand (e.g., APOE ε4 for Alzheimer's risk), the modifiable factors retain their effect sizes — often more so, because the absolute risk is higher.

How to evaluate "longevity interventions"

A useful filter when reading any new claim:

  1. What's the evidence type?

    • Animal data only → very weak human applicability
    • Surrogate biomarker change in humans → suggestive but unproven
    • RCT with hard endpoint → the gold standard
    • Mendelian randomization → strong causal inference, often deflates observational claims
  2. Who funded the study? Industry-funded longevity supplement trials systematically over-report positives.

  3. Is the population relevant? A signal in 80-year-olds with sarcopenia may not generalize to a healthy 45-year-old.

  4. What's the absolute effect size? A "30% relative risk reduction" of a rare event is small absolutely. Lifestyle interventions usually beat supplements on absolute terms.

  5. What's the alternative? Sometimes the best intervention is removing a harm (smoking, ultra-processed food, untreated OSA), not adding a new one.


— § —